142 related articles for article (PubMed ID: 35082928)
21. Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.
Bizhani F; Hashemi M; Danesh H; Nouralizadeh A; Narouie B; Bahari G; Ghavami S
EXCLI J; 2018; 17():3-13. PubMed ID: 29383014
[TBL] [Abstract][Full Text] [Related]
22. Breast Cancer Risk-Associated SNPs in the
Chen Q; Deng X; Hu X; Guan S; He M; Wang Y; Wei B; Zhang J; Zhao H; Yao W; Jin F; Liu Y; Chen J; Olapade OI; Wu H; Wei M
Mol Cancer Res; 2019 Nov; 17(11):2244-2256. PubMed ID: 31467112
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of the association between mTORC1-related genes polymorphisms and cancer risk.
Lu X; Liu M; Liao Y; Huang C; Chai L; Jin Y; Xiong Q; Chen B
Pathol Res Pract; 2022 Jan; 229():153696. PubMed ID: 34839094
[TBL] [Abstract][Full Text] [Related]
24. CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the potential risk in tumorigenicity of urinary cancer: A systematic review and meta-analysis.
Fan S; Meng J; Zhang L; Zhang X; Liang C
Pathol Res Pract; 2019 Jan; 215(1):151-158. PubMed ID: 30463805
[TBL] [Abstract][Full Text] [Related]
25. Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.
Huang L; Huang J; Wu P; Li Q; Rong L; Xue Y; Lu Q; Li J; Tong N; Wang M; Zhang Z; Fang Y
Leuk Lymphoma; 2012 May; 53(5):947-51. PubMed ID: 21973240
[TBL] [Abstract][Full Text] [Related]
26. Genetic variants in mTOR-pathway-related genes contribute to osteoarthritis susceptibility.
Xu Z; Yang H; Zhou X; Li J; Jiang L; Li D; Wu L; Huang Y; Xu N
Int Immunopharmacol; 2019 Dec; 77():105960. PubMed ID: 31704287
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in mTORC1 genes modulate risk of esophageal squamous cell carcinoma in eastern Chinese populations.
Zhu ML; Yu H; Shi TY; He J; Wang MY; Li QX; Sun MH; Jin L; Yang YJ; Wang JC; Xiang JQ; Wei QY
J Thorac Oncol; 2013 Jun; 8(6):788-95. PubMed ID: 23524405
[TBL] [Abstract][Full Text] [Related]
28. Impact of
Wang M; Ma SJ; Wu XY; Zhang X; Abesig J; Xiao ZH; Huang X; Yan HP; Wang J; Chen MS; Tan HZ
World J Clin Cases; 2020 Oct; 8(19):4320-4330. PubMed ID: 33083391
[TBL] [Abstract][Full Text] [Related]
29. Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer.
Piao Y; Li Y; Xu Q; Liu JW; Xing CZ; Xie XD; Yuan Y
PLoS One; 2015; 10(8):e0136447. PubMed ID: 26317520
[TBL] [Abstract][Full Text] [Related]
30. Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer.
Qi L; Sun K; Zhuang Y; Yang J; Chen J
J BUON; 2017; 22(6):1488-1493. PubMed ID: 29332342
[TBL] [Abstract][Full Text] [Related]
31. Gene polymorphisms in the PI3K/AKT/mTOR signaling pathway contribute to prostate cancer susceptibility in Chinese men.
Liu T; Gulinaer A; Shi X; Wang F; An H; Cui W; Li Q
Oncotarget; 2017 Sep; 8(37):61305-61317. PubMed ID: 28977864
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants in PI3K/Akt/mTOR pathway genes contribute to gastric cancer risk.
Ge Y; Liu H; Qiu X; Ma G; Wang H; Du M; Wang M; Zhao Q; Tao G; Chu H; Zhang Z
Gene; 2018 Sep; 670():130-135. PubMed ID: 29802999
[TBL] [Abstract][Full Text] [Related]
33. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.
Chen M; Cassidy A; Gu J; Delclos GL; Zhen F; Yang H; Hildebrandt MA; Lin J; Ye Y; Chamberlain RM; Dinney CP; Wu X
Carcinogenesis; 2009 Dec; 30(12):2047-52. PubMed ID: 19875696
[TBL] [Abstract][Full Text] [Related]
34. The transcription factor MZF1 differentially regulates murine
Zhang S; Shi W; Ramsay ES; Bliskovsky V; Eiden AM; Connors D; Steinsaltz M; DuBois W; Mock BA
J Biol Chem; 2019 Nov; 294(45):16756-16764. PubMed ID: 31548308
[TBL] [Abstract][Full Text] [Related]
35. SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant Recipients.
Husen P; Straub K; Willuweit K; Hagemann A; Wedemeyer H; Bachmann HS; Herzer K
Transplant Proc; 2019; 51(6):1962-1971. PubMed ID: 31303410
[TBL] [Abstract][Full Text] [Related]
36. Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer.
Lin J; Wang J; Greisinger AJ; Grossman HB; Forman MR; Dinney CP; Hawk ET; Wu X
Cancer Prev Res (Phila); 2010 Apr; 3(4):505-17. PubMed ID: 20354165
[TBL] [Abstract][Full Text] [Related]
37. Association of cytokine gene polymorphisms with susceptibility to cutaneous leishmaniasis in a Turkish population.
Kirik FE; Ülger M; Tezcan Ülger S; Aslan G
Parasite Immunol; 2020 Nov; 42(11):e12775. PubMed ID: 32656817
[TBL] [Abstract][Full Text] [Related]
38. Association of CDKN1B gene polymorphisms with susceptibility to breast cancer: a meta-analysis.
Xiang H; Li H; Ge W; Wu W; Gao M; Wang W; Hong L; Jiang D; Zhang C
Mol Biol Rep; 2013 Nov; 40(11):6371-7. PubMed ID: 24078094
[TBL] [Abstract][Full Text] [Related]
39. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
40. [Association of genetic polymorphisms of key molecules in JAK/STAT signaling pathway with susceptibility of hepatocellular carcinoma].
Xie JX; Yin JH; Zhang Q; Pu R; Zhang YW; Lu WY; Cao GW
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Feb; 33(2):215-9. PubMed ID: 22575147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
